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Abstract Hyperchromasia of the red blood cells (RBC),
defined as an elevation of the hyperchromic subpopulation,
has been described for various medical conditions. However,
neither the association of hyperchromasia with an altered
RBC membrane nor with other medical conditions has been
investigated in a systematic way so far. Since the percentage
of hyperchromic RBC is measured on a routine basis by
many hematologic laboratories, we evaluated the predictive
value of this parameter for the detection of RBC disorders.
An extensive workup of all patients undergoing standard
hematogram during a period of 6 months at our institution
with a fraction of hyperchromic RBC larger than 10 % was
collected by reviewing the medical history and performing
osmotic gradient ektacytometry on RBC from a part of these
patients. Thirty-two thousand two hundred twenty-six indi-
viduals were screened; of which, 162 (0.5 %) showed more
than 10 % hyperchromic RBC. All of the patients examined
by ektacytometry featured abnormal membrane deformabil-
ity. Hereditary spherocytosis was found in 19 out of these 32
patients, in most cases unknown to the patient and currently
asymptomatic. Another 17.9 % of the patients with an elevat-
ed subpopulation of hyperchromic RBC suffered from viral
infection (human immunodeficiency virus, hepatitis). Our
study shows that an elevated proportion of hyperchromic
erythrocytes larger than 10 % is associated with both heredi-
tary and acquired RBC membrane disorders and further
follow-up should be considered.
Keywords Hyperchromasia . Spherocytosis . Red blood
cells . Membrane
Introduction
Hyperchromasia of the red blood cells (RBC) is a common
feature of various conditions and has been described espe-
cially for hereditary spherocytosis (HS) [1] but also for
various others, such as listed in Table 1 [2–4]. Hyperchro-
masia, defined as an elevated percentage of hyperchromic
RBC, can be predictive for an altered RBC membrane even
in the absence of an elevated mean cellular hemoglobin
concentration (MCHC) [5].
HS is a common form of hereditary RBC membranopa-
thies. Symptoms range from asymptomatic forms to occa-
sional severe diseases requiring splenectomy and regular
transfusions; a large portion of patients are asymptomatic
and unaware of their condition [6]. In general practice, HS is
typically diagnosed by osmotic fragility testing [7, 8]; how-
ever, mild forms of hereditary RBC membranopathies with
only limited hemolytic activity are often difficult to identify
[9]. In these cases, osmotic fragility tests have a poor sensi-
tivity and at least 20 % of mild cases of HS are missed [3]. In
contrast to this, osmotic gradient ektacytometry with the
simultaneous recording of deformability against the solute
concentration remains a gold standard for the diagnosis of
altered erythrocyte deformability [6, 10]. However, this assay
is technically challenging, requiring cumbersome calibration
J. W. Deuel : J. S. Goede (*)
Division of Hematology, University Hospital of Zurich,
Rämistrasse 100,
8091 Zurich, Switzerland
e-mail: jeroen.goede@usz.ch
H. U. Lutz
Institute of Biochemistry, ETH Zurich,
Zurich, Switzerland
B. Misselwitz
Divison of Gastroenterology, University Hospital of Zurich,
Zurich, Switzerland
Ann Hematol (2012) 91:1427–1434
DOI 10.1007/s00277-012-1467-5
and freshly obtained blood, and is, therefore, not suitable as a
screening test in clinical routine.
Regarding the existing literature, it has to be noted that
the significance of hyperchromasia as an isolated laboratory
parameter is unclear and its clinical interpretation poses a
major challenge. However, neither the association of hyper-
chromasia with an altered RBC membrane nor with other
medical conditions, such as viral infection, has been investi-
gated in a systematic way until now. The percentage of hyper-
chromic RBC has been used before as a screening tool for
RBC membranopathies [11]; however, no rigorous follow-up
of patients was attempted and the diagnostic significance of an
elevated percentage of hyperchromic RBC remains unclear.
In this paper, we present a systematic study of patients
showing a marked elevation of the hyperchromic RBC
subpopulation. To detect altered RBC membrane deformabil-
ity at a high level of sensitivity, we used osmotic gradient
ektacytometry. By reviewing the medical history of hyper-
chromic patients, we were also able to detect an association
with other pathological conditions such as viral infections.
Design and methods
Comparing the percentage of hyperchromic RBCs
with MCHC
To evaluate the distribution of the percentage of hyperchro-
mic RBCs and MCHC in our patient population, we
assessed all patients undergoing standard hematogram at
the central hematologic laboratory in the University
Hospital of Zurich within a period of 2 months (Fig. 1). If
samples of a patient were measured on several occasions,
only the sample with the highest percentage of hyperchro-
mic RBC was considered. All hematograms were analyzed
by an ADVIA 120 (Siemens, Forchheim, Germany). Eryth-
rocytes with a corpuscular hemoglobin concentration of
more than 410 g/l were considered hyperchromic, whereas
the upper limit for the mean corpuscular hemoglobin con-
centration (MCHC) is defined as 360 g/l. To minimize
measurement errors, all samples with an obvious patholog-
ical deviation of a measurement on hematological parame-
ters were measured at least twice.
All hematological parameters measured by the ADVIA
system, including the hyperchromic RBC fraction, were
calibrated and quality controlled on a regular basis, comply-
ing with good laboratory practice. The linear range of single
cell hemoglobin concentration measured by the ADVIA
system ranges from 0 to 500 g/l. Statistical analysis was
done using Graphpad Prism.
Patient recruitment and data collection
From all patients undergoing a standard hematogram during
a period of 6 months (February until August 2008), we
selected all individuals with 10 % or more hyperchromic
erythrocytes. This cutoff value was arbitrarily chosen to
include approximately 0.3 % of all patients. The medical
Table 1 Known conditions causing hyperchromasia of RBC
Hereditary RBC membranopathies such as HS
AIHA
Microangiopathic and macroangiopathic hemolytic anemias
HELLP syndrome
Hemolytic transfusion reactions
Cytotoxic treatment
Artificial heart valves
Massive myocardial infarction
Acute oxidant injury
Thermal injuries
Liver disease
Clostridial sepsis
Zinc toxicity
Poisoning by certain snake, spider, and hymenoptera venoms
Severe hypophosphatemia
Hypersplenism
Severe hypoosmolality of the plasmaa
a Pseudohyperchromasia due to an artifact of the automatic determina-
tion of the RBC indices
Fig. 1 Plot of MCHC as a function of the fraction of hyperchromic RBC.
Fourteen thousand nine hundred eighty-eight measurements of patients at
our institution during a period of 2 months are shown. The vertical lines
indicate the upper and lower limits of normal (>360 and <310 g/l, respec-
tively). Similarly, the upper reference value for the fraction of hyper-
chromic RBC (2 %) and our inclusion criterion (10 %) are indicated as
horizontal lines. The number of patients in each section of the plot is given
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history of the selected patients was reviewed and patients
were classified as discussed below (Fig. 2). An elevated
proportion of hyperchromic RBC in patients with one or
more known reasons for an acquired disease (Table 1) was
considered acquired. If a hereditary membranopathy such as
HS, explaining the elevated fraction of hyperchromic eryth-
rocytes, had been diagnosed before, the patient was catego-
rized as known congenital. All other patients were classified
as having an unknown condition. Medical chart review
revealed evidence for viral infections such as hepatitis B
or C or human immunodeficiency virus (HIV) in many
cases; therefore, we divided the unknown cases into two
subgroups: Patients with and without documented viral in-
fection. Cases of the latter group were excluded from further
follow-up if the hyperchromic fraction had been within the
normal range at least once in the past (not persistent). Even
though an occasional presence of a normal fraction of hyper-
chromic erythrocytes in the patient’s history does not ex-
clude a congenital cause with certainty, it at least makes a
transient or acquired cause more likely. For the remaining
individuals (possibly congenital), a workup was done by
determining the size of the spleen and performing a Coombs
test and osmotic gradient ektacytometry on their RBC. For
comparison and as internal controls, we tested several
patients with a fraction of hyperchromic RBC increased to
more than 10 % and known congenital hyperchromasia,
documented viral infection, and acquired reasons for
hyperchromasia.
Osmotic gradient ektacytometry
RBC deformability was studied with an ektacytometer
(Technikon, Bayer, Leverkusen, Germany) in the osmoscan
mode as described [10, 12–14]. Thereby, deformability of
erythrocytes was measured by laser diffractometry. Deform-
ability was plotted against the extracellular osmolality of a
viscous solution of 20 % dextran that provides a constant
shear stress at increasing osmolality. Dextran with an aver-
age molecular weight of 70 kDa was used (Carl Roth
GmbH, Karlsruhe, Germany); this solution was buffered
with 10 mM NaKHPO4 to minimize the effect of pH on
deformability [15] and also contained glucose (5.6 mM) and
sodium azide (0.4 g/L). The osmolality gradient was
obtained by adding sodium chloride to the solution in one
compartment of the gradient mixer. The Technikon ektacy-
tometer measures conductivity of the RBC suspension close
to the diffractometer. The system was calibrated beforehand
by measuring the ektacytometer’s conductivity on a series of
solutions differing in osmolality by cryoscopic osmometry
(Gonotec Osmomat 030). An aliquot of 500 μl whole blood,
collected in a standard 10-ml BD K2H Vacutainer® (18.0 mg
of K2EDTA), was mixed with 3 ml of isoosmolal dextran
solution and directly inserted into the ektacytometer for
measurement of RBC deformability. Blood samples were
processed within 1–4 h after donation and incubated at room
temperature prior to mixing with dextran. All samples were
measured twice; both values consistently showed an almost
Fig. 2 Study design. During 6 months, all hematograms acquired were
reviewed. Patient records were analyzed retrospectively if the hyper-
chromic RBC fraction was larger than 10 %. Patients with a known
RBC disorder or a known condition leading to an elevation of hyper-
chromic RBC were thus classified as having a known congenital or an
acquired hyperchromasia. All other patients (unknown) were separated
into patients with and without documented viral infection. Patients
with nonpersistent elevation of hyperchromic RBCs were excluded
from follow-up. The condition of the remaining patients was regarded
as possibly congenital. Of these, 24 could be further classified by
osmotic gradient ektacytometry
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perfect correlation. The analog output of the Technikon
ektacytometer was digitalized using a 12-bit A/D-Converter
(NI USB-6008, National Instruments, Austin, TX, USA).
On the digitalized osmoscan obtained, the following points
were calculated: Pmax—the point of maximal deformability
index (DI) and Pmin—the point of minimal DI (in the hypo-
osmolal branch). In addition, the osmolalities where half the
DI of Pmax was reached on both the hypoosmolal branch (P′
A) and the hyperosmolal branch (P′B) were recorded
(Fig. 3a). In order to compare the results from patients and
controls, we also recorded and analyzed osmoscans from 30
healthy volunteers. From these data, an averaged osmoscan
profile was calculated. The respective range (double stan-
dard deviation) of the four points Pmin, Pmax, P′A, and P′B
are indicated as boxes in the graphs (Fig. 3). These reference
values were used for qualitative and quantitative evaluation
of patients’ samples.
Determination of Pmin, Pmax, P′A, and P′B for HS
To acquire discriminatory values from osmoscans of HS
patients, we reviewed 15 osmoscans from patients with
proven HS. Ten of these patients had a spectrin/ankyrin
deficiency and five had a band 3 deficiency as verified by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) [10]. The osmoscans had been obtained be-
tween 1999 and 2004 and were not digitalized but plotted
onto paper. Therefore, the four characteristic points were
determined manually from the plots.
Results
Comparing the percentage of hyperchromic RBCs with
MCHC
We evaluated standard hematograms acquired during a pe-
riod of 2 months at our institution. Thirty-eight thousand
five hundred seventy-nine samples of 14,988 individuals
were tested. Overall, values obtained for MCHC and the
percentage of hyperchromic erythrocytes (Fig. 1) correlated
strongly (r00.6, p<0.0001, Spearman’s rank correlation).
Interestingly, this correlation was weaker at the extremes of
both parameters (MCHC >360 g/l and percentage of hyper-
chromatic RBCs >10 %), confirming that MCHC and per-
centage of hyperchromatic RBCs cannot be used
interchangeably. Of note, only 63 % of the 40 patients with
more than 10 % or more hyperchromatic RBCs had an
MCHC above the cutoff. Vice versa, only 14 % of the 250
patients with an MCHC >360 g/l had a percentage of hyper-
chromatic RBCs of 10 % or above.
Analysis of patients with more than 10 % hyperchromic
RBC
Hematograms from 32,226 individual patients were ana-
lyzed during a period of 6 months at the Division of Hema-
tology of the University Hospital of Zurich. Out of these
samples, 162 (0.50 %) contained more than 10 % hyper-
chromic RBC (Fig. 2). Review of patients’ records revealed
an acquired reason for this finding in 37 patients (22.8 %):
An ongoing cytotoxic treatment was the most frequent
Fig. 3 Osmoscans. a Characteristic points of osmoscans. Pmin is the
point of 50 % hemolysis. Pmax is the point of maximal deformability.
On the hyperosmolal and hypoosmolal branches of the osmoscan, the
osmolality at which half the maximal deformability (half DI of Pmax) is
reached are correspondingly defined as P′A and P′B. b Patients with a
known hereditary membranopathy of the RBC. Three patients show
different forms of HS (green), one patient has cryohydrocytosis (red).
The ektacytometric features of HS consist of Pmax with deformability
well below the normal range, though at a normal osmolality, and often
an increased osmolality of Pmin, indicating a diminished osmotic
resistance. The osmolality of P′A is increased, whereas that of P′B is
shifted to hypoosmolal conditions. For comparison, we added the mean
curve of 30 healthy donors (blue) into all the following osmoscans. The
blue boxes indicate the normal range of the four characteristic points
Pmax, Pmin, P′A, and P′B (double standard deviations). c Osmoscans of
patients with possibly congenital elevation of the hyperchromic RBC
fraction revealing a pattern of HS. Fourteen patients’ osmoscans (red)
reveal a mild form of HS, whereas 2 (purple) impress as more pro-
nounced forms of HS. All osmoscans show the typical features of HS
with a decreased maximal deformability and a loss of cellular solutes.
The osmolality at which Pmin is reached is for the majority of cases
only slightly higher than that of the controls. This implies a minute
reduction of the osmotic resistance and probably explains why all of
these patients were asymptomatic. d Osmoscans of HS patients with
SDS-PAGE confirmed membrane protein deficiencies. The black
points originate from five patients with band 3 deficiency, the red
points from ten patients with spectrin/ankyrin deficiency. The averages
of the characteristic points for the two types of disorders are marked by
asterisks in the corresponding colors. e Osmoscans from patients with
possibly congenital elevation of the hyperchromic RBC fraction re-
vealing a viral pattern. Pmin and P′A are in the normal range, Pmax is
slightly diminished and shifted to hypoosmolality, whereas P′B shows
a clear shift to hypoosmolality. This solitary shift is characteristic for
aged RBC having lost solutes prematurely. The normal osmolality of
Pmin indicates a normal osmotic resistance of the RBC from these
patients. f Osmoscans from two patients with documented viral infec-
tion. These osmoscans are very similar to those shown in Fig. 3e. g
Osmoscans from two patients with acquired membranopathies. One
patient was undergoing cytotoxic treatment (green curve) and one
patient had AIHA, shown in red. h Osmoscans from four patients with
possibly congenital elevation of the hyperchromic RBC fraction re-
vealing unknown patterns. We could not assign these osmoscans to a
specific RBC membranopathy, even though all curves suggest some
sort of membrane disorder. The green curve fits to the pattern of a mild
form of dehydrated stomatocytosis, with all characteristic points being
shifted to hypoosmolality and the maximal deformability being only
slightly diminished. The red curve possibly shows a borderline type of
HS, with a slightly diminished osmotic fragility (Pmin) and a slightly
diminished maximal deformability (Pmax). The brown curve shows a
pattern reminiscent of a viral infection, except for the right shift of the
left arm of the osmoscan
b
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condition identified, explaining the elevated hyperchromic
fraction of RBC in 27 patients; the 10 remaining patients
summarized under the heading other causes included 3 with
autoimmune hemolytic anemia (AIHA), 3 with severe plas-
ma hypoosmolality, and 1 each with hemolysis, elevated
liver enzymes, and low platelets (HELLP) syndrome, an
aortic valve defect, a massive myocardial infarction, and
recent surgery for aortocoronary bypass. The group of
patients with a known congenital explanation for the eleva-
tion of hyperchromic erythrocytes comprised six individuals
(3.7 %) including five patients with HS and one with cry-
ohydrocytosis [16], based on current and previous hemato-
logic records at our hospital. For 119 patients (73.5 %),
classified as unknown, we found no explanation for the
elevated hyperchromic fraction. In these cases, we did not
find evidence for any of the known reasons for hyperchro-
masia. Instead, 29 of these 119 patients were found to have
acute or chronic viral infection. Most of these patients (22)
were infected with HIV, 14 of them under documented
antiretroviral therapy regimen. Some patients were infected
with hepatitis C virus (seven, thereof three coinfections with
HIV). Few patients suffered from chronic (two) or acute
(one) hepatitis B virus infection.
For 23 of the remaining patients, hyperchromasia was not
persistent; in these cases, we postulated an acquired cause.
Finally, for a group of 66 patients, the elevation of the
hyperchromic fraction was unexplained and likely to be
persistent; this group would include patients with undiag-
nosed possibly congenital RBC membranopathies. Labora-
tory findings of the different groups are shown in Table 2.
Ektacytometry was performed on 32 subjects; 4 of these
were of the known congenital group (3 HS and 1
cryohydrocytosis) and were aware of their condition. Their
osmoscans are shown in Fig. 3b, illustrating a mild case of
HS, two pronounced cases of HS, and one case of geneti-
cally confirmed cryohydrocytosis [16]. Sixteen of the
remaining 28 patients examined by ektacytometry showed
osmoscans characteristic for HS, with 14 displaying a mild
form of HS and 2 displaying a more pronounced form of HS
(Fig. 3c). None of these patients had been diagnosed with
HS before.
Next, we compared the osmoscans of these newly diag-
nosed patients with the osmoscans of previously described
HS patients [10] (Fig. 3d); the type of HS in the latter
individuals had been determined by SDS-PAGE [10, 17],
demonstrating band 3 deficiencies (five patients, black sym-
bols) and spectrin/ankyrin deficiencies (ten patients, red
symbols). Importantly, the osmoscans of both groups
showed virtually overlapping characteristics: A signifi-
cantly decreased maximal deformability and a lower
surface to volume ratio, as indicated by a left shift of
the hyperosmolal arm of the osmoscan. There is no
doubt that the diagnosis for all patients whose osmo-
scans are shown in Fig. 3c, d is HS due to the charac-
teristic osmoscans pattern.
In addition to HS, our analysis also revealed other char-
acteristic osmoscan patterns; for example, a group of four
patients with a possibly congenital elevation of the hyper-
chromic RBC fraction showed osmoscans in which the left
arm was virtually identical to the controls, but the right arm
was shifted to lower osmolalities (Fig. 3e). This pattern is
highly similar to the osmoscans of two patients with docu-
mented viral infection, as shown in Fig. 3f. The underlying
pathophysiological reasons of this osmoscan pattern are
Table 2 Basic characteristics of patient groups
Units (reference) Acquired Congenital Unknown
Cytotoxic Other Not persistent Possibly
congenital
Viral
Number of patients 27 10 6 23 66 29
Sex M/F 15:12 5:5 4:2 20:3 48:19 27:2
Age Years 54 (18–90) 54 (20–89) 36 (20–44) 60 (25–104) 41 (21–84) 46 (26–73)
Hemoglobin g/l (117–170) 115 (73–155) 117 (65–152) 148 (130–172) 153 (130–172) 143 (81–176) 144 (48–176)
Reticulocytes % (0.40–2.50) 3.35 (0.00–10.42) 4.78 (1.7–15.16) 2.34 (1.50–3.94) 2.43 (0.57–5.64) 2.94 (0.94–12.30) 1.87 (0.48–4.43)
MCHC g/l (310–360) 364 (275–383) 370 (348–391) 364 (283–394) 371 (360–383) 370 (267–398) 372 (356–384)
MCV fl (80–100) 91.0 (82.6–101.0) 85.7 (80.6–92.8) 82.8 (76.7–85.9) 86.2 (79.0–98.4) 85.2 (25.3–98.4) 90.5 (39.6–101.1)
MCH pg (26–34) 33.4 (29.9–38.4) 31.7 (29.6–34.9) 31.6 (28.7–33.1) 31.9 (29.5–36.1) 32.5 (27.5–68.7) 34.4 (29.3–43.8)
LDH U/l (240–420) 477 (224–791) 1,120 (400–4,656) 449 (357–546) 531 (240–1,980) 427 (236–791) 486 (66–790)
Bilirubin μmol/l (<21) 93 (7–819) 39 (6–109) 33 (27–39) 15 (4–31) 15 (5–36) 33 (9–80)
Neutrophils 109/l (1.4–8.0) 5.90 (0.90–20.30) 12.65 (2.10–47.80) 5.57 (3.00–8.80) 5.07 (1.20–19.10) 5.58 (0.50–46.30) 3.25 (1.20–6.70)
Lymphocytes 109/l (1.5–4.0) 1.02 (0.09–2.80) 6.70 (0.40–54.70) 2.36 (1.19–5.24) 1.37 (0.34–4.16) 2.53 (0.54–43.10) 1.82 (0.28–3.44)
Thrombocytes 109/l (143–400) 216 (35–471) 173 (34–310) 386 (196–851) 207 (71–366) 243 (32–547) 186 (28–366)
The mean and the range of the observed values are indicated
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unclear; since such a pattern seems to accompany several
viral diseases, we refer to it as a viral pattern.
Furthermore, the remaining four tested patients assigned
to the possibly congenital group had unique osmoscans,
with one fitting the diagnosis of dehydrated stomatocytosis
[18] (Fig. 3h, green line). The remaining three could not be
assigned to a specific disorder (Fig. 3h), pointing to as yet
uncharacterized membranopathies or atypical presentations
of known conditions. Interestingly, as shown in Fig. 3g, the
osmoscans of two patients with acquired reasons for hyper-
chromasia including one patient with AIHA and one after
cytotoxic therapy also showed a characteristic pattern not
shared by any other group. Importantly, none of the patients
with >10 % hyperchromic erythrocytes had a normal osmo-
scan pattern.
Discussion
In this study, we screened a large number of patients using
the percentage of hyperchromic RBC and did a follow-up of
patients with more than 10 % hyperchromic erythrocytes.
Follow-up of these patients revealed a potentially relevant
medical condition in the majority of these patients. Our data,
therefore, argue for the clinical value of an elevated fraction
of hyperchromic RBCs as a noteworthy parameter. If the
percentage of hyperchromic RBCs is elevated to more than
10 % and an acquired condition for this shift can be excluded,
further follow-up including tests for viral infections and hered-
itary membranopathies should be considered.
The majority of patients with more than 10 % hyper-
chromic erythrocytes also have an elevated MCHC; however,
this correlation is not strict: More than a third shows an
MCHC within the normal range. Vice versa, an elevation of
the MCHC is also not strictly associated with a marked
elevation of hyperchromic erythrocytes, indicating a certain
independency of these parameters.
Among all patients undergoing a standard hematogram at
our institution during a period of 6 months, 162 (0.5 %)
were found with more than 10 % hyperchromic RBC. Sixty-
six of these patients (41 %) remained as candidates for a
congenital but so far undiagnosed RBC membrane disorder.
None of the 32 patients examined by ektacytometry
revealed a normal pattern of RBC deformability. Sixteen
thereof were found with osmoscans typical for HS
(Fig. 3c); all of them without clinical symptoms. Osmoscans
allowed the classification into a mild form of HS (14
patients) and a pronounced form (2 patients), in agreement
with other clinical findings (Table 3). Comparisons of these
osmoscans with those recorded from patients with known
membrane protein deficiencies confirmed that all of these
newly discovered patients have HS.
According to our data, the prevalence of HS is compara-
ble to previously published data [19, 20] and may be higher
than generally considered. Assuming that the patients tested
by ektacytometry would be representative for the “possibly
congenital” patient group, the number of HS-positive
patients in this group can be extrapolated to be 44 (67 %).
Adding the 5 patients with previously known HS, the esti-
mated number of HS patients within the 162 patients with
hyperchromasia greater than 10 % would be 49 (30 %). The
prevalence of HS in our collective of 32,226 patients can be
calculated to be at least 1:650. Since the sensitivity of our
screening test “hyperchromasia >10 %” is not known, an
unknown number of HS patients might have been missed by
our study and the prevalence of HS would be even higher.
However, it is not known whether the patient collective
undergoing standard hematogram analysis at our institution
is representative for the Swiss population.
Interestingly, we frequently identified viral infections in
patients with more than 10 % hyperchromic RBC. In fact, of
the 119 patients with neither a known congenital membran-
opathy nor a condition for an acquired hyperchromasia, 29
(24 %) had a documented viral infection, typically hepatitis
or HIV, strongly indicating that these infections can cause
hyperchromasia. To the best of our knowledge, this associ-
ation has not been described previously. One explanation for
our finding would be an accelerated clearance of older RBC
following certain viral infections, a phenomenon which
could account for a decrease of the right arm of the osmo-
scan inhibition [21, 22]. In agreement with this interpreta-
tion, the mean reticulocyte count was within the normal
Table 3 Characteristics of
patients studied by
ektacytometry
The mean and the range of the
observed values are indicated
Reference Viral Mild HS Pronounced
HS
Unknown
Number of
patients
4 14 2 4
Spleen
diameter
mm (<120) 130 (122–137) 140 (130–155) 136 (101–170) 136 (185–230)
Reticulocytes % (0.4–2.5) 2.0 (1.2–2.5) 2.5 (1.8–4.4) 6.4 (3.8–9.0) 6.1 (2.6–12.3)
Hemoglobin g/l (117–170) 154 (135–162) 152 (139–176) 108 (87–128) 136 (81–165)
LDH U/l (240–420) 382 (314–449) 373 (343–398) 531 (492–570) 543 (308–778)
Bilirubin μmol/l (<21) 22 (10–34) 14 (5–36) 30 (28–31) 14 (7–21)
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range among the four cases studied by ektacytometry (Table 3).
Whether such a premature clearance of older RBC is due to side
effects of antiviral medication, which many of the patients with
viral infections received, remains to be studied.
In our study, congenital RBC membranopathies, which
are considered contraindications for blood donations by
several institutions [23], were detected at a surprisingly high
rate. Furthermore, some of the remaining patients suffered
from viral infections including HIV. However, any potential
benefit of such an additional test for the safety of a blood
donation can only be demonstrated by a prospective study.
The osmoscans of RBC from healthy donors only show
minute variations (Fig. 3), whereas those of RBC from
patients with an acquired or hereditary hyperchromasia
show a broad spectrum of variance, depending on the cause
of hyperchromasia. Importantly, some osmoscan patterns
could not be attributed to any of the known RBC
membranopathies, potentially pointing to as yet undis-
covered RBC abnormalities or disorders. The consider-
ably elevated spleen diameters (Table 2) found in
patients of this group support this hypothesis. These
considerations clearly support a careful workup of these
patients including acidified glycerol lysis test and eosin-
5′-maleimide binding test [24].
Taken together, our study suggests an elevated fraction of
hyperchromic RBC as a simple test for hyperchromasia to
screen for hereditary RBC membrane disorders. Since this
test identifies individuals with contraindications for blood
transfusion, the use of this parameter could potentially im-
prove the quality of blood donations.
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